Opinion: A role for intestinal mycoplasmas in the aetiology of Crohn's disease?

Journal of Applied Microbiology

Volumn 92, Issue 3, 2002, Pages 377-381

  Roediger, W E W ^a   Macfarlane, G T ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; CROHN DISEASE; HUMAN; INTESTINE; MICROBIOLOGY; MYCOPLASMA; PATHOGENICITY; REVIEW; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM DETECTION; COLON MUCOSA; ELECTRON MICROSCOPY; NONHUMAN;

CROHN DISEASE; HUMANS; INTESTINES; MYCOPLASMA; MYCOPLASMA INFECTIONS;

ATYPICALS; CLINICAL STUDY; CROHN DISEASE; DIGESTIVE TRACT; DISEASE ETIOLOGY; EPITHELIAL CELLS; GASTROINTESTINAL TRACT; HELICOBACTER; INFLAMMATORY DISORDERS; INTRACELLULAR STRUCTURES;

DISEASES;

ANTIBIOTIC AGENT; CHOLESTEROL; CLARITHROMYCIN; CLOFAZIMINE; ETHAMBUTOL; LIPOPROTEIN; RIFABUTIN;

DISEASE; ETIOLOGY;

ATYPICAL MYCOBACTERIUM; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; CORYNEBACTERINEAE; MYCOPLASMA; MYCOPLASMATALES;

EID: 0036122235     PISSN: 13645072     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2672.2002.01531.x     Document Type: Review

References (55)

1. Electron microscopy in Crohn's disease
2. The macrolides: Erythromycin, clarithromycin and azithromycin
3. Mycoplasma in the upper gastrointestinal tracts of southern Indian control subjects and patients with tropical sprue
4. Treatment of severe Crohn's disease (CD) using rifabutin-macro-lide-clofazimine combination: Interim report
5. Attempts to produce granulomatous colitis in boxer dogs with mycoplasma
6. Trends in incidence rates of ulcerative colitis and Crohn's disease
7. Infectious agents in inflammatory bowel disease (IBD): A status report
8. Interactions between mycoplasma lipoproteins and the host immune system
9. Antibiotics in Crohn's disease
10. Regional ileitis. A pathological and clinical entity
11. Intracellular DNA replication and long-term survival of pathogenic mycoplasmas
12. Chronic interstitial enteritis
13. Fusion of Mycoplasma fermentans strain incognitus with T Iymphocytes
14. Fat composition is the differential factor to explain the primary therapeutic effect of enteral nutrition in Crohn's disease. Results of a double-blind randomized multicentre European trial
15. Isolation of Mycoplasma moatsii from intestine of wild Norway rats (Rattus norvegicus)
16. Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn's disease
17. Isolation of a mycoplasma from the intestinal tract of cattle
18. Isolation of mycoplasmas from porcine rectal swabs
19. Two year outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics
20. Mycoplasma pneumoniae virulence factors and the immune response
21. Mycoplasmas in chronic ulcerative colitis: A negative study
22. Mycoplasma contamination in cell culture of Crohn's disease material
23. Autologous bone marrow transplantation for non-Hodgkin's lymphoma resulting in long-term remission of coincidental Crohn's Disease
24. Mycoplasmas which infect humans
25. The role of mycoplasmas in human reproductive failure
26. Infectious history
27. Open label trial of oral clarithromycin in active Crohn's disease
28. Mycoplasmas and AIDS
29. Course of Crohn's disease after allogeneic marrow transplantation
30. Eaton Agent - Science and scientific acceptance: A historical commentary
31. Similarities of mycoplasma species isolated from man and from non-human primates
32. Does micro particle transcytosis occur across human colon mucosa?
33. The prevalence of Ureaplasma urealyticum and mycoplasma in the cervix and anal canal of women
34. Cell wall defective variants of pseudomonas like (group Va) bacteria in Crohn's disease
35. Review article: The management of severe Crohn's disease
36. The mycoplasmas
37. The genera Mycoplasma
38. Mycoplasma adhesion
39. A new hypothesis for the aetiology of Crohn's disease - Evidence from lipid metabolism and intestinal tuberculosis
40. Crohn's disease: An adjuvant disease?
41. Does exclusion of enteral lipid assist remission in Crohn's disease?
42. Host- pathogen interactions in mycoplasma pathogenesis: Virulence and survival strategies of minimalist prokaryotes
43. Subversion and exploitation of host cells by mycoplasmas
44. Membrane lipids of Mycoplasma hominis
45. Cholesterol in mycoplasma membranes
46. Clarithromycin in active Crohn's disease (CD): Preliminary results of an open label pilot study
47. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
48. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation
49. Structure and functions of lamellar bodies, lipid - Protein complexes involved in storage and secretion of cellular lipids
50. The role of mycobacteria in Crohn's disease
51. Intestinal fine structure in Crohn's disease. Lysosomal inclusions in epithelial cells and macrophages
52. High frequency of antibodies to Mycoplasma penetrans in HIV infected patients
53. Uber das vorkommen von mycoplasma im anorektalbereich der frau
54. Possible role of Mycoplasma fermentans in pathogenesis of rheumatoid arthritis